Moderna's New Lower-Dose COVID-19 Vaccine, mNexspike, Approved by FDA
Drugs.com
JUNE 3, 2025
TUESDAY, June 3, 2025 -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The new vaccine (mNexspike [COVID-19 Vaccine.
Let's personalize your content